These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 3030900)

  • 21. Effect of dietary fiber on symptoms and rectosigmoid motility in patients with irritable bowel syndrome. A controlled, crossover study.
    Cook IJ; Irvine EJ; Campbell D; Shannon S; Reddy SN; Collins SM
    Gastroenterology; 1990 Jan; 98(1):66-72. PubMed ID: 2152777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ispaghula husk may relieve gastrointestinal symptoms in ulcerative colitis in remission.
    Hallert C; Kaldma M; Petersson BG
    Scand J Gastroenterol; 1991 Jul; 26(7):747-50. PubMed ID: 1654592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Demonstration of differences in colonic volumes, transit, chyme consistency, and response to psyllium between healthy and constipated subjects using magnetic resonance imaging.
    Major G; Murray K; Singh G; Nowak A; Hoad CL; Marciani L; Silos-Santiago A; Kurtz CB; Johnston JM; Gowland P; Spiller R
    Neurogastroenterol Motil; 2018 Sep; 30(9):e13400. PubMed ID: 30062794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of chronic diarrhoea: loperamide versus ispaghula husk and calcium.
    Qvitzau S; Matzen P; Madsen P
    Scand J Gastroenterol; 1988 Dec; 23(10):1237-40. PubMed ID: 3074458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of ispaghula husk on the faecal output of bile acids in healthy volunteers.
    Chaplin MF; Chaudhury S; Dettmar PW; Sykes J; Shaw AD; Davies GJ
    J Steroid Biochem Mol Biol; 2000 Apr; 72(5):283-92. PubMed ID: 10822018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of irritable bowel syndrome with lorazepam, hyoscine butylbromide, and ispaghula husk.
    Ritchie JA; Truelove SC
    Br Med J; 1979 Feb; 1(6160):376-8. PubMed ID: 32949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Effect of Psyllium Husk on Intestinal Microbiota in Constipated Patients and Healthy Controls.
    Jalanka J; Major G; Murray K; Singh G; Nowak A; Kurtz C; Silos-Santiago I; Johnston JM; de Vos WM; Spiller R
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30669509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative study of the effects on colon function caused by feeding ispaghula husk and polydextrose.
    Tomlin J; Read NW
    Aliment Pharmacol Ther; 1988 Dec; 2(6):513-9. PubMed ID: 2979274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective 5-hydroxytryptamine type 3 receptor antagonism with ondansetron as treatment for diarrhea-predominant irritable bowel syndrome: a pilot study.
    Steadman CJ; Talley NJ; Phillips SF; Zinsmeister AR
    Mayo Clin Proc; 1992 Aug; 67(8):732-8. PubMed ID: 1434911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of wheat bran on weight of stool and gastrointestinal transit time: a meta analysis.
    Müller-Lissner SA
    Br Med J (Clin Res Ed); 1988 Feb; 296(6622):615-7. PubMed ID: 2832033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of bran, ispaghula, and inert plastic particles on gastric emptying and small bowel transit in humans: the role of physical factors.
    McIntyre A; Vincent RM; Perkins AC; Spiller RC
    Gut; 1997 Feb; 40(2):223-7. PubMed ID: 9071936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The long-term safety and tolerability of ispaghula husk.
    Oliver SD
    J R Soc Promot Health; 2000 Jun; 120(2):107-11. PubMed ID: 10944885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of ispaghula husk and guar gum on postprandial glucose and insulin concentrations in healthy subjects.
    Sierra M; Garcia JJ; Fernández N; Diez MJ; Calle AP; Sahagún AM;
    Eur J Clin Nutr; 2001 Apr; 55(4):235-43. PubMed ID: 11360127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of the effect of increased dietary fibre intake on bowel function in patients with spinal cord injury.
    Cameron KJ; Nyulasi IB; Collier GR; Brown DJ
    Spinal Cord; 1996 May; 34(5):277-83. PubMed ID: 8963975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fecal weight, colon cancer risk, and dietary intake of nonstarch polysaccharides (dietary fiber).
    Cummings JH; Bingham SA; Heaton KW; Eastwood MA
    Gastroenterology; 1992 Dec; 103(6):1783-9. PubMed ID: 1333426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of medicinal fiber on colonic transit in patients with irritable colon syndrome].
    Soifer LO; De Paula JA; Caruso P
    Acta Gastroenterol Latinoam; 1987; 17(4):317-23. PubMed ID: 2849850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Double blind trial of ispaghula/poloxamer in the Irritable Bowel Syndrome.
    Arthurs Y; Fielding JF
    Ir Med J; 1983 May; 76(5):253. PubMed ID: 6307924
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of coarse wheat bran in the irritable bowel syndrome. A double-blind cross-over study.
    Arffmann S; Andersen JR; Hegnhøj J; Schaffalitzky de Muckadell OB; Mogensen NB; Krag E
    Scand J Gastroenterol; 1985 Apr; 20(3):295-8. PubMed ID: 2988107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral domperidone: double blind comparison with placebo in irritable bowel syndrome.
    Cann PA; Read NW; Holdsworth CD
    Gut; 1983 Dec; 24(12):1135-40. PubMed ID: 6357963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dietary intakes and stool characteristics of patients with the irritable bowel syndrome.
    Hillman LC; Stace NH; Fisher A; Pomare EW
    Am J Clin Nutr; 1982 Oct; 36(4):626-9. PubMed ID: 6289655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.